Feed SRRK
SR

Scholar Rock

SRRK · NASDAQ

$49.37 -1.28% (-$0.64)
1M -9.78%
Market Cap $5.92B
P/E Ratio -
Div. Yield -
ROE 160.19%

Bulios Fair Price

$43.63

11.6% downside

Trenutna cena

$49.37

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica SRRK trenutno precenjena glede na svojo tržno ceno. Kako deluje?

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Piotroski F-Score Weak
2/9
Valuation
0 /100
Expensive
P/B 23.31x
P/E N/A
EV/EBITDA N/A
Growth
15 /100
Declining
Book val. growth 1.93%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A
Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
0 /100
Poor
ROIC 88.80%
ROE 160.19%
Asset turnover 0.00x
Debt
52 /100
Moderate
Debt/Equity 0.80x
Current ratio 7.02x
Int. coverage -37.23x
Stability
71 /100
Stable
Beta 0.68x
EPS volatility 22.75%
Profitable years 0

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o SRRK
Online

O podjetju

Scholar Rock Holding Corporation is a U.S.-based biotechnology company focused on developing therapeutics that specialize in innovative approaches to modulating biological signaling pathways. The company concentrates on developing drugs that target proteins and signaling molecules involved in cell growth and development, particularly in the fields of neurology, oncology, and immunology. Scholar Rock is positioned as a leader in highly targeted therapies with the potential to transform the treatment of a range of serious and previously difficult-to-treat diseases.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Biotechnology

CEO

David L. Hallal

Employees

289

Headquarters

Cambridge

Prihajajoči dogodki

13 NOV.

Earnings

Upcoming earnings report

57d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.